Managing Adverse Events of Immunotherapy in Breast Cancer
Last Updated: Friday, January 13, 2023
Hatem Soliman, MD, Associate Member of Breast Oncology and Immunology and Medical Director of the Clinical Trials Office at Moffitt Cancer Center, answers questions on the most common adverse events associated with immunotherapy, how to address them, and whether immune-related adverse events predict response to treatment.
Advertisement
News & Literature Highlights